Search Results - "EISTERER, W"

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER) by Moehler, M., Maderer, A., Thuss-Patience, P.C., Brenner, B., Meiler, J., Ettrich, T.J., Hofheinz, R.-D., Al-Batran, S.E., Vogel, A., Mueller, L., Lutz, M.P., Lordick, F., Alsina, M., Borchert, K., Greil, R., Eisterer, W., Schad, A., Slotta-Huspenina, J., Van Cutsem, E., Lorenzen, S.

“…Palliative chemotherapy of advanced oesophageal squamous cell cancer (ESCC) consists of cisplatin/5-fluorouracil (CF) to target epidermal growth factor…”
Get full text

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08) by Ruhstaller, T., Thuss-Patience, P., Hayoz, S., Schacher, S., Knorrenschild, J.R., Schnider, A., Plasswilm, L., Budach, W., Eisterer, W., Hawle, H., Mariette, C., Hess, V., Mingrone, W., Montemurro, M., Girschikofsky, M., Schmidt, S.C., Bitzer, M., Bedenne, L., Brauchli, P., Stahl, M.

“…This open-label, phase III trial compared chemoradiation followed by surgery with or without neoadjuvant and adjuvant cetuximab in patients with resectable…”
Get full text

Reply to the letter to the editor ‘Anti-EGFR therapy in oesophagogastric cancer: precise but not enough’ by M. Salati and S. Cascinu by Ruhstaller, T., Langer, R., Thuss-Patience, P., Eisterer, W., Stahl, M.

Get full text

Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer: Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial by Kogler, P., DeVries, A. F., Eisterer, W., Thaler, J., Sölkner, L., Öfner, D.

“…Purpose The major goals of preoperative treatment for locally advanced rectal cancers (LARCs) are improvement of local tumor control, tumor downsizing, and…”
Get full text

The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study by Riedl, J., Posch, F., Prager, G., Eisterer, W., Öhler, L., Thamer, S., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Längle, F., Wöll, E., Gerger, A.

Get full text

Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine by Eisterer, W., Gerger, A., Öhler, L., Mlineritsch, B., Sliwa, T., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Wöll, E., Neumann, H., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., Gruenberger, B., Längle, F., Prager, G.

Get full text

Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease by EISTERER, W, JIANG, X, AUEWARAKUL, C, BARNETT, M. J, EAVES, C. J, EAVES, A. C, CHRIST, O, GLIMM, H, LEE, K. H, PANG, E, LAMBIE, K, SHAW, G, HOLYOAKE, T. L, PETZER, A. L

“…Xenograft models of chronic phase human chronic myeloid leukemia (CML) have been difficult to develop because of the persistence of normal hematopoietic stem…”
Get full text

Feasibility of a multdisciplinary lung cancer videoconference between a peripheral hospital and a comprehensive cancer centre by Seeber, A, Mitterer, M, Gunsilius, E, Mazzoleni, G, Giovannetti, R, Farsad, M, Eisterer, W, Gastl, G, Pall, G, Wieser, A, Lukas, P, Wimmer, M, Spizzo, G

“…Treatment of lung cancer patients is changing rapidly and new treatment options have emerged in recent years. In 2007, to guarantee the best treatment…”
Get more information

The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) by Ploner, F., Lamm, W., Schur, S., Eisterer, W., Kühr, T., Lindorfer, A., Tinchon, C., Köstler, W. J., Szkandera, J., Brodowicz, T.

“…Purpose The purpose of this retrospective analysis was to assess efficacy and tolerability of trabectedin in soft tissue sarcoma (STS) in the routine clinical…”
Get full text

CD44 Variant Isoforms in Non-Hodgkin's Lymphoma: A New Independent Prognostic Factor by Stauder, Reinhard, Eisterer, Wolfgang, Thaler, Josef, Gunthert, Ursula

“…Isoforms of the transmembrane glycoprotein CD44, generated by alternative RNA splicing, have been correlated to tumor dissemination. For evaluation of the…”
Get full text

RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy by Eisterer, W., Erb, H., Haslbauer, F., Sormann, S., Braun, S., Jaeger, C.

“…Abstract Background: Anaemia is a highly prevalent condition in cancer patients impacting on morbidity, mortality and quality of life. Darbepoetin alfa (DA)…”
Get full text

Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography by Traub-Weidinger, T, Von Guggenberg, E, Dobrozemsky, G, Kendler, D, Eisterer, W, Bale, R, Putzer, D, Gabriel, M, Virgolini, I

“…Positron emission tomography (PET) of (68)Ga-radiolabelled (SST) somatostatin receptor (R) binding peptides has recently been evaluated in SSTR positive tumor…”
Get full text

Unfulfilled Promise of Endostatin in a Gene Therapy-Xenotransplant Model of Human Acute Lymphocytic Leukemia by Eisterer, Wolfgang, Jiang, Xiaoyan, Bachelot, Thomas, Pawliuk, Robert, Abramovich, Carolina, Leboulch, Philippe, Hogge, Donna, Eaves, Connie

“…Retroviral transduction of hematopoietic stem cells (HSCs) offers an attractive strategy for treating malignancies that home to the marrow. This approach…”
Get full text

Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) by WÖLL, E, KÜHR, T, EISTERER, W, GATTRINGER, K, GREIL, R, ZABERNIGG, A, HILBE, W, THALER, J

“…The aim of the study was to evaluate the feasibility and efficacy of an outpatient oxaliplatin/irinotecan chemotherapy in chemonaive patients suffering from…”
Get full text

CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia by Bechter, Oliver E, Eisterer, Wolfgang, Dlaska, Margit, Kühr, Thomas, Thaler, Josef

“…Expression of the catalytic subunit of the telomerase enzyme hTERT is essential for prolonging the replicative lifespan and is the rate-limiting step in…”
Get full text

Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis by Hilbe, W, Dirnhofer, S, Oberwasserlechner, F, Eisterer, W, Ammann, K, Schmid, T, Hilbe, G, Thaler, J, Wöll, E

“…Aims: To investigate the immunohistochemical expression of a panel of biologically relevant markers in patients with non-small cell lung cancer using fresh…”
Get full text

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma by Eisterer, W., Bechter, O., Hilbe, W., van Driel, M., Lokhorst, H.M., Thaler, J., Bloem, A.C., Günthert, U., Stauder, R.

“…To evaluate the role of CD44 variant isoforms (CD44v) in plasma cell dyscrasias, CD44v expression was analysed in bone marrow (BM) biopsies of multiple myeloma…”
Get full text

Characterization of Human Hematopoietic Cells with Short-Lived in Vivo Repopulating Activity by Eaves, C., Glimm, H., Eisterer, W., Audet, J., Maguer-Satta, V., Pireta, J.

“…: Recent studies with purified hematopoietic stem cells in vitro support a model of stem cell self‐renewal control that involves distinct mechanisms regulating…”
Get full text

An aggressive subtype of B-CLL is characterized by strong CD44 expression and lack of CD11c by Eistere, W, Hilbe, W, Stauder, R, Bechter, O, Fend, F, Thaler, J

“…In a retrospective study based on 107 B-CLL patients, the expression of the adhesion molecules CD44, CD11a, CD11b, CD11c, CD18, CD25 and CD54 was analysed in…”
Get more information

Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia by JIANG, X, FUJISAKI, T, NICOLINI, F, BERGER, M, HOLYOAKE, T, EISTERER, W, EAVES, C, EAVES, A

“…Neoplastic CD34+ cells from chronic myeloid leukemia (CML) patients proliferate in vitro in the absence of serum or defined growth factors due to an autocrine…”
Get full text